Advertisement

Topics

Signostics Limited Company Profile

14:55 EDT 24th June 2018 | BioPortfolio


News Articles [31 Associated News Articles listed on BioPortfolio]

EchoNous Announces Biomedical Engineers and Managers Receive Hands-On Preview of New Multi-Function, Vascular and Bladder Nursing Platform at AAMI 2018

Pending FDA 510k clearance, new vein finding tool will enable first ever multi-function nursing platform alongside AI-driven bladder tool EchoNous, a developer of intel...

Critical Care Nurses Attending NTI 2018 Will Have Hands-On Preview of EchoNous’ New Vein Finding Tool

Pending FDA 510k clearance, new vein finding tool is designed to improve first-time peripheral IV (PIV) placement and help improve HCAHPS patient satisfaction scores Ec...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

Quotient Limited Reports Commencement of EU Blood Grouping Field Trial

JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [86 Associated Companies listed on BioPortfolio]

Signostics Limited

Signostics Inc.

Signostics is a leader in handheld ultrasound devices and bladder scanners. Products include the SignosRT ultrasound system and the SignosRT Bladder, both ultra-portable, affordab...

Signostics Ltd.

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Signostics Limited" on BioPortfolio

We have published hundreds of Signostics Limited news stories on BioPortfolio along with dozens of Signostics Limited Clinical Trials and PubMed Articles about Signostics Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Signostics Limited Companies in our database. You can also find out about relevant Signostics Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record